CCWM
RMD icon

Cassaday & Co Wealth Management’s ResMed RMD Stock Holding History

Cassaday & Co Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$195 Hold
1
– – ﹤0.01% 1222
2026
Q1 		$225 Buy
+1
New +$249 ﹤0.01% 1256

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cassaday & Co Wealth Management's RMD Position: Q2 2026 in Review

Cassaday & Co Wealth Management held its ResMed (RMD) position steady in Q2 2026 at 1 share worth $195. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

Cassaday & Co Wealth Management first reported a position in RMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $225 in Q1 2026. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Cassaday & Co Wealth Management held 1 share of ResMed worth $195 as of Q2 2026.
  • Cassaday & Co Wealth Management left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #1222 holding.
  • Cassaday & Co Wealth Management first reported a position in ResMed in Q1 2026 and has held it in 2 quarters since.
  • Cassaday & Co Wealth Management's ResMed position peaked at $225 in Q1 2026.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.